NO20006430D0 - Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner - Google Patents

Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner

Info

Publication number
NO20006430D0
NO20006430D0 NO20006430A NO20006430A NO20006430D0 NO 20006430 D0 NO20006430 D0 NO 20006430D0 NO 20006430 A NO20006430 A NO 20006430A NO 20006430 A NO20006430 A NO 20006430A NO 20006430 D0 NO20006430 D0 NO 20006430D0
Authority
NO
Norway
Prior art keywords
depression
anxiety
nerve
prevention
treatment
Prior art date
Application number
NO20006430A
Other languages
English (en)
Other versions
NO20006430L (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20006430D0 publication Critical patent/NO20006430D0/no
Publication of NO20006430L publication Critical patent/NO20006430L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20006430A 1998-06-25 2000-12-15 Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner NO20006430L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000425A IT1299195B1 (it) 1998-06-25 1998-06-25 Composizione ad attivita' neuroprotettiva per la prevenzione ed il trattamento delle alterazioni nervose e comportamentali legate a stati
PCT/IT1999/000175 WO1999066914A2 (en) 1998-06-25 1999-06-17 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin

Publications (2)

Publication Number Publication Date
NO20006430D0 true NO20006430D0 (no) 2000-12-15
NO20006430L NO20006430L (no) 2001-02-21

Family

ID=11406010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006430A NO20006430L (no) 1998-06-25 2000-12-15 Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner

Country Status (26)

Country Link
US (1) US6346282B1 (no)
EP (1) EP1089744B1 (no)
JP (1) JP2002518438A (no)
KR (1) KR20010053059A (no)
CN (1) CN1307479A (no)
AT (1) ATE228369T1 (no)
AU (1) AU756542B2 (no)
BR (1) BR9912179A (no)
CA (1) CA2334858C (no)
DE (1) DE69904173T2 (no)
DK (1) DK1089744T3 (no)
EE (1) EE200000729A (no)
ES (1) ES2188178T3 (no)
HU (1) HUP0102546A3 (no)
IL (1) IL140159A0 (no)
IS (1) IS5765A (no)
IT (1) IT1299195B1 (no)
MA (1) MA26651A1 (no)
NO (1) NO20006430L (no)
NZ (1) NZ508882A (no)
PL (1) PL194177B1 (no)
PT (1) PT1089744E (no)
SK (1) SK19302000A3 (no)
TN (1) TNSN99135A1 (no)
TR (1) TR200003736T2 (no)
WO (1) WO1999066914A2 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
DE10015617A1 (de) * 2000-03-29 2001-10-04 Peter Laetzsch Migränemittel
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
DE10213571A1 (de) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Pflanzenextrakte und deren Anwendung
US7674482B2 (en) * 2002-08-27 2010-03-09 Targeted Medical Pharma Inc. Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
US20040067986A1 (en) * 2002-10-04 2004-04-08 Nathan Sassover Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer
WO2004110963A2 (en) * 2003-05-29 2004-12-23 Pettegrew Jay W Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20070065486A1 (en) * 2004-05-21 2007-03-22 Migco Limited Migraine remedy
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
EP1835287A3 (de) * 2006-03-14 2007-10-24 Wilfried P. Bieger Verfahren und Testbestecke zur Bestimmung von neuroendokrinen gesundheitlichen Störungen
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
BRPI0921679A2 (pt) * 2008-11-11 2016-02-16 Sigma Tau Ind Farmaceuti composto útil para tratar celulite
BRPI0900614A2 (pt) 2009-02-13 2011-06-28 Univ Fed Do Rio Grande Do Sul Ufrgs extrato vegetal neuroativo, composição farmacêutica compreendendo o mesmo e processo para sua produção
PT2582368T (pt) * 2010-06-16 2018-06-04 Alfasigma Spa Acetil-carnitina, para utilização num método para o aumento da neurogénese em tecido neuronal
ES2575995T3 (es) 2010-08-05 2016-07-04 Case Western Reserve University Inhibidores de ERK para trastornos del desarrollo de la conectividad neuronal
JP2014145857A (ja) 2013-01-28 2014-08-14 Sony Corp 表示装置およびその製造方法、並びに電子機器
WO2016126169A1 (ru) * 2015-02-04 2016-08-11 Общество С Ограниченной Ответственностью "Консорциум-Пик" Способ повышения эффективности терапии антидепрессантом в комплексной антидепрессивной терапии и фармацевтическая комбинация

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
DE4239959A1 (de) * 1992-11-27 1994-06-01 Schwabe Willmar Gmbh & Co Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5911992A (en) * 1997-06-12 1999-06-15 A. Glenn Braswell Method for controlling weight with hypericum perforatum and garcinia cambogia

Also Published As

Publication number Publication date
HUP0102546A3 (en) 2003-08-28
CN1307479A (zh) 2001-08-08
IL140159A0 (en) 2002-02-10
DE69904173D1 (de) 2003-01-09
EP1089744B1 (en) 2002-11-27
SK19302000A3 (sk) 2001-09-11
NZ508882A (en) 2002-06-28
EP1089744A2 (en) 2001-04-11
CA2334858C (en) 2010-08-24
US6346282B1 (en) 2002-02-12
KR20010053059A (ko) 2001-06-25
BR9912179A (pt) 2001-04-10
ITRM980425A1 (it) 1999-12-25
PT1089744E (pt) 2003-04-30
ES2188178T3 (es) 2003-06-16
MA26651A1 (fr) 2004-12-20
WO1999066914A2 (en) 1999-12-29
TR200003736T2 (tr) 2001-06-21
TNSN99135A1 (fr) 2005-11-10
IS5765A (is) 2000-12-08
ITRM980425A0 (it) 1998-06-25
AU4391099A (en) 2000-01-10
NO20006430L (no) 2001-02-21
DK1089744T3 (da) 2003-03-24
PL194177B1 (pl) 2007-05-31
CA2334858A1 (en) 1999-12-29
HUP0102546A2 (hu) 2001-10-28
WO1999066914A3 (en) 2000-04-06
PL345279A1 (en) 2001-12-03
DE69904173T2 (de) 2003-08-28
IT1299195B1 (it) 2000-02-29
JP2002518438A (ja) 2002-06-25
EE200000729A (et) 2002-06-17
AU756542B2 (en) 2003-01-16
ATE228369T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
DK1089744T3 (da) Neurobeskyttende præparat til forebyggelse og/eller behandling af nervøse og adfærdsmæssige ændringer på grund af angsttilstande eller depression omfattende acetyl-L-carnitin og hypericin
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
ATE212546T1 (de) Behandlung von neurodegenerativen zuständen mittels nimesulide
DE60138019D1 (de) Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
DE69925816D1 (de) Metall chelatoren zur verwendung in der behandlung von alzheimers erkrankung mit clioquinol
ATE210449T1 (de) Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards
DE59704654D1 (de) Verwendung eines Extraktes aus Cimicifuga racemosa
DE69818939D1 (de) Rosaceae extrakt als bradykinin-antagonist
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DK0988040T3 (da) Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
BR9808784A (pt) Método para o tratamento de doença mental em mamìferos e uma composição para o mesmo
DE59900222D1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
ATE339216T1 (de) Murraya koenigii-extrakte zur behandlung von asthma
ATE253924T1 (de) Pharmazeutisch wirksames, pflanzliches präparat zur behandlung von migräne
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE466587T1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe
ATE284705T1 (de) Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen
ATE355071T1 (de) Kräuterzusammensetzung enthaltend calendula und eucalyptus für die behandlung und heilung von erkrankungen
MY128938A (en) A herbal composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application